EWOPHARMA NEW DISTRIBUTOR
We are happy to announce that Calmino group AB and Ewopharma (Schaffhausen, Switzerland) have entered into an exclusive distribution agreement for the territories of the Czech Republic and Slovakia to launch PROIBS® for the treatment of symptoms related to IBS. This agreement includes all marketing and sales activities of PROIBS® as of April 2022. “With […]
